{"id":"W2083751586","doi":"10.15273/dmj.vol39no2.3738","title":"A Review of Novel Anticoagulants","year":2013,"lang":"en","type":"review","venue":"Dalhousie Medical Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Rivaroxaban; Apixaban; Dabigatran; Medicine; Atrial fibrillation; Warfarin; Vitamin k; Anticoagulant; Venous thromboembolism; Intensive care medicine; Discovery and development of direct thrombin inhibitors; Stroke (engine); Cardiology; Internal medicine; Thrombosis; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001394719,0.0003510683,0.003598214,0.0002963627,0.00005425052,0.00002297927,0.0003486644,0.000355597,0.005821171],"category_scores_gemma":[0.002315332,0.0002074232,0.001344742,0.0004046047,0.0001109954,0.00006815102,0.0001566596,0.000913267,0.0002374404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005393691,"about_ca_system_score_gemma":0.0009522187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003335968,"about_ca_topic_score_gemma":1.8213e-7,"domain_scores_codex":[0.9960318,0.0001376282,0.001820481,0.0002235839,0.001468268,0.0003182439],"domain_scores_gemma":[0.9974636,0.0002672394,0.001113236,0.0003495482,0.0002098277,0.0005965586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00000346453,0.00002477572,0.00002945204,0.1649196,0.0003935682,0.00009051719,0.000004347966,7.224779e-9,1.585477e-7,0.00004335371,0.02790224,0.8065885],"study_design_scores_gemma":[0.0005096327,0.00004949725,0.00001433616,0.3087205,0.00216012,0.001968205,0.000001871535,0.000005219891,7.06065e-8,0.000003218959,0.686446,0.0001213681],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001165175,0.9947154,0.0005119737,0.001321844,0.0007602622,0.000920211,0.000009826903,0.00002822305,0.001731121],"genre_scores_gemma":[2.263193e-7,0.993395,0.0009316813,0.001338294,0.003000168,0.00000361754,0.00006821786,0.00005247055,0.00121027],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8064671,"threshold_uncertainty_score":0.9950876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1974751679081404,"score_gpt":0.4417680493821492,"score_spread":0.2442928814740088,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}